Bristol-Myers Squibb Co/ US1101221083 /
02/01/2025 19:43:01 | Diferencia +0.20 | Volumen | Bid19:43:42 | Ask19:43:42 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
56.81USD | +0.35% | 170,735 Volumen de negocios: 9.73 millones |
56.81Volumen de oferta: 200 | 62.50Tamaño/ Volumen/ Formato de Ask: 110 | 115.26 mil millonesUSD | 4.06% | 14.65 |
GlobeNewswire
03/09/2024
Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
GlobeNewswire
02/09/2024
CSE Announces its 2024 Sustainability & ESG Leadership Summit at NYC's One World Trade Center
GlobeNewswire
30/08/2024
Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
28/08/2024
Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire
22/08/2024
Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire
15/08/2024
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire
12/08/2024
Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
Newsfile Corp
12/08/2024
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire
12/08/2024
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
GlobeNewswire
08/08/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
07/08/2024
Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Diseas...
GlobeNewswire
05/08/2024
iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
GlobeNewswire
01/08/2024
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire
01/08/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire
31/07/2024
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Boar...
GlobeNewswire
25/07/2024
Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
GlobeNewswire
24/07/2024
Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado
GlobeNewswire
20/07/2024
NCLA Asks Third Circuit to Rule Against HHS’s Coercive Medicare Drug Price ‘Negotiation’ Program
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página